Thiopurine S-methyltransferase Genetic Polymorphism and Its Contribution for Azathioprine-Induced Myelosuppression in Kidney Transplant Recipients: A Summative Analysis. - Suppr | 超能文献

Thiopurine S-methyltransferase Genetic Polymorphism and Its Contribution for Azathioprine-Induced Myelosuppression in Kidney Transplant Recipients: A Summative Analysis.

作者信息

Sookaromdee Pathum, Wiwanitkit Viroj

机构信息

Private Academic Consultant, Bangkok, Thailand.

Department of Community Medicine, Dr. D. Y. Patil University, Pune, Maharashtra, India.

出版信息

Saudi J Kidney Dis Transpl. 2020 Sep-Oct;31(5):1154-1155. doi: 10.4103/1319-2442.301189.

DOI:10.4103/1319-2442.301189

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Thiopurine S-methyltransferase Genetic Polymorphism and Its Contribution for Azathioprine-Induced Myelosuppression in Kidney Transplant Recipients: A Summative Analysis.

Saudi J Kidney Dis Transpl. 2020 Sep-Oct;31(5):1154-1155. doi: 10.4103/1319-2442.301189.

2

Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand.杂合子TPMT*1/*3C基因型对泰国肾移植受者硫唑嘌呤诱导的骨髓抑制的影响。

Clin Ther. 2009 Jul;31(7):1524-33. doi: 10.1016/j.clinthera.2009.07.008.

3

Thiopurine S-methyltransferase polymorphism in Iranian kidney transplant recipients.伊朗肾移植受者中的硫嘌呤甲基转移酶多态性

Exp Clin Transplant. 2011 Aug;9(4):241-6.

4

The frequency and significance of thiopurine S-methyltransferase gene polymorphisms in azathioprine-treated renal transplant recipients.硫唑嘌呤治疗的肾移植受者中硫嘌呤S-甲基转移酶基因多态性的频率及意义

Br J Dermatol. 2006 Jun;154(6):1199-200. doi: 10.1111/j.1365-2133.2006.07239.x.

5

The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.硫嘌呤甲基转移酶基因多态性对肾移植受者硫唑嘌呤诱导的骨髓毒性的影响。

Ther Drug Monit. 2005 Aug;27(4):435-41. doi: 10.1097/01.ftd.0000164393.09402.c9.

6

Association of thiopurine S-methyltransferase and NUDT15 polymorphisms with azathioprine-induced myelotoxicity in Chinese patients with rheumatological disease.硫嘌呤甲基转移酶和NUDT15基因多态性与中国风湿性疾病患者硫唑嘌呤诱导的骨髓毒性的相关性

Chin Med J (Engl). 2020 Apr 20;133(8):1002-1004. doi: 10.1097/CM9.0000000000000756.

7

Severe azathioprine-induced myelotoxicity in a kidney transplant patient with thiopurine S-methyltransferase-deficient genotype (TPMT*3A/*3C).硫嘌呤甲基转移酶缺陷基因型（TPMT*3A/*3C）的肾移植患者发生严重的硫唑嘌呤诱导的骨髓毒性。

Transpl Int. 2005 May;18(5):623-5. doi: 10.1111/j.1432-2277.2005.00095.x.

8

Azathioprine myelosuppression in multiple sclerosis: characterizing thiopurine methyltransferase polymorphisms.硫唑嘌呤在多发性硬化症中的骨髓抑制作用：硫嘌呤甲基转移酶多态性的特征分析

Mult Scler. 2006 Feb;12(1):108-11. doi: 10.1191/135248506ms1249cr.

9

Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism.携带TPMT*3C基因多态性的系统性红斑狼疮患者中硫唑嘌呤诱导的致命性骨髓抑制。

Lupus. 2008 Feb;17(2):132-4. doi: 10.1177/0961203307085255.

10

Azathioprine and diffuse alveolar haemorrhage: the pharmacogenetics of thiopurine methyltransferase.硫唑嘌呤与弥漫性肺泡出血：硫嘌呤甲基转移酶的药物遗传学

Eur Respir J. 2007 Nov;30(5):1014-7. doi: 10.1183/09031936.00026107.

引用本文的文献

1

Pharmacogenetics in Acute Lymphoblastic Leukemia: Synthesizing Progress for Personalized Thiopurine Therapy.急性淋巴细胞白血病中的药物遗传学：为个性化硫嘌呤治疗整合进展

Med Sci (Basel). 2025 Aug 5;13(3):112. doi: 10.3390/medsci13030112.

2

MethPhaser: methylation-based long-read haplotype phasing of human genomes.MethPhaser：基于甲基化的人类基因组长读长单倍型相位分析。

Nat Commun. 2024 Jun 22;15(1):5327. doi: 10.1038/s41467-024-49588-0.